Djaballah H, Rowe A J, Harding S E, Rivett A J
Department of Biochemistry, University of Leicester, U.K.
Biochem J. 1993 Jun 15;292 ( Pt 3)(Pt 3):857-62. doi: 10.1042/bj2920857.
The multicatalytic proteinase complex or proteasome is a high-molecular-mass multisubunit proteinase which is found in the nucleus and cytoplasm of eukaryotic cells. Electron microscopy of negatively stained rat liver proteinase preparations suggests that the particle has a hollow cylindrical shape (approximate width 11 nm and height 17 nm using methylamine tungstate as the negative stain) with a pseudo-helical arrangement of subunits rather than the directly stacked arrangement suggested previously. The side-on view has a 2-fold rotational symmetry, while end-on there appears to be six or seven subunits around the ring. This model is very different from that proposed by others for the proteinase from rat liver but resembles the structure of the simpler archaebacterial proteasome. The possibility of conformational changes associated with the addition of effectors of proteolytic activity has been investigated by sedimentation velocity analysis and dynamic light-scattering measurements. The results provide the first direct evidence for conformational changes associated with the observed positive co-operativity in one component of the peptidylglutamylpeptide hydrolase activity as well as with the stimulation of peptidylglutamylpeptide hydrolase activities by MnCl2. In the latter case, there appears to be a correlation between changes in the shape of the molecule and the effect on activity. KCl and low concentrations of SDS may also act by inducing conformational changes within the complex. Sedimentation-velocity measurements also provide evidence for the formation of intermediates during dissociation of the complex by urea, guanidinium chloride or sodium thiocyanate. Dissociation of the complex either by these agents or by treatment at low pH leads to inactivation of its proteolytic components. The results suggest that activation and inhibition of the various proteolytic activities may be mediated by measurable changes in size and shape of the molecules.
多催化蛋白酶复合体或蛋白酶体是一种高分子量的多亚基蛋白酶,存在于真核细胞的细胞核和细胞质中。对经负染色的大鼠肝脏蛋白酶制剂进行电子显微镜观察表明,该颗粒呈空心圆柱形(以甲基胺钨酸盐作为负染色剂时,宽度约为11纳米,高度约为17纳米),亚基呈假螺旋排列,而非先前认为的直接堆叠排列。侧面观察具有二重旋转对称性,而从端部观察,环周围似乎有六个或七个亚基。该模型与其他人提出的大鼠肝脏蛋白酶模型有很大不同,但类似于更简单的古细菌蛋白酶体的结构。通过沉降速度分析和动态光散射测量,研究了与蛋白水解活性效应物添加相关的构象变化可能性。结果首次直接证明了与肽基谷氨酰肽水解酶活性的一个组分中观察到的正协同作用以及与MnCl2对肽基谷氨酰肽水解酶活性的刺激相关的构象变化。在后一种情况下,分子形状的变化与对活性的影响之间似乎存在相关性。KCl和低浓度的SDS也可能通过诱导复合物内的构象变化而起作用。沉降速度测量还为复合物在尿素、氯化胍或硫氰酸钠作用下解离过程中中间体的形成提供了证据。复合物被这些试剂解离或在低pH下处理都会导致其蛋白水解组分失活。结果表明,各种蛋白水解活性的激活和抑制可能是由分子大小和形状的可测量变化介导的。